ResMed Inc. (RMD)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 31.91B |
| Enterprise value | 32.84B |
| Trailing P/E | 33.41 |
| Forward P/E | 26.60 |
| PEG ratio (5-yr expected) | 1.97 |
| Price/sales (ttm) | 6.99 |
| Price/book (mrq) | 6.89 |
| Enterprise value/revenue | 7.16 |
| Enterprise value/EBITDA | 21.81 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.67 |
| 52-week change 3 | -7.95% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 240.09 |
| 52-week low 3 | 132.24 |
| 50-day moving average 3 | 187.45 |
| 200-day moving average 3 | 172.35 |
Share statistics
| Avg vol (3-month) 3 | 1.09M |
| Avg vol (10-day) 3 | 1.73M |
| Shares outstanding 5 | 146.91M |
| Implied shares outstanding 6 | 147.68M |
| Float 8 | 145.47M |
| % held by insiders 1 | 0.82% |
| % held by institutions 1 | 58.77% |
| Shares short (15 Apr 2024) 4 | 7.95M |
| Short ratio (15 Apr 2024) 4 | 7.89 |
| Short % of float (15 Apr 2024) 4 | 6.16% |
| Short % of shares outstanding (15 Apr 2024) 4 | 5.40% |
| Shares short (prior month 15 Mar 2024) 4 | 7.66M |
Dividends & splits
| Forward annual dividend rate 4 | 1.92 |
| Forward annual dividend yield 4 | 0.88% |
| Trailing annual dividend rate 3 | 1.88 |
| Trailing annual dividend yield 3 | 0.86% |
| 5-year average dividend yield 4 | 0.87 |
| Payout ratio 4 | 28.92% |
| Dividend date 3 | 13 June 2024 |
| Ex-dividend date 4 | 08 May 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 31 Aug 2010 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 June 2021 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 20.91% |
| Operating margin (ttm) | 31.29% |
Management effectiveness
| Return on assets (ttm) | 11.91% |
| Return on equity (ttm) | 22.39% |
Income statement
| Revenue (ttm) | 4.58B |
| Revenue per share (ttm) | 31.17 |
| Quarterly revenue growth (yoy) | 7.20% |
| Gross profit (ttm) | N/A |
| EBITDA | 1.44B |
| Net income avi to common (ttm) | 958.38M |
| Diluted EPS (ttm) | 6.49 |
| Quarterly earnings growth (yoy) | 29.20% |
Balance sheet
| Total cash (mrq) | 259.45M |
| Total cash per share (mrq) | 1.77 |
| Total debt (mrq) | 1.17B |
| Total debt/equity (mrq) | 25.21% |
| Current ratio (mrq) | 3.04 |
| Book value per share (mrq) | 31.52 |
Cash flow statement
| Operating cash flow (ttm) | 1.2B |
| Levered free cash flow (ttm) | 955.85M |
© 2024 Yahoo. All rights reserved.